A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity
CompletedOBSERVATIONAL
Enrollment
82
Participants
Timeline
Start Date
May 6, 2019
Primary Completion Date
February 29, 2020
Study Completion Date
February 29, 2020
Conditions
AnticoagulantApixabanObesity
Interventions
DIAGNOSTIC_TEST
Anti Xa levels
one Blood sample
Trial Locations (1)
18101
HaEmek Medical Center, Afula
All Listed Sponsors
lead
HaEmek Medical Center, Israel
OTHER
NCT03893591 - A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity | Biotech Hunter | Biotech Hunter